SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-014436
Filing Date
2017-08-10
Accepted
2017-08-10 17:02:11
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20170630_10q.htm 10-Q 1319928
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14442
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14524
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6983
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 7250
  Complete submission text file 0001437749-17-014436.txt   4397802

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kmph-20170630.xml EX-101.INS 747208
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20170630.xsd EX-101.SCH 37525
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20170630_cal.xml EX-101.CAL 33080
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20170630_def.xml EX-101.DEF 299970
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20170630_lab.xml EX-101.LAB 233028
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20170630_pre.xml EX-101.PRE 306928
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 171022160
SIC: 2834 Pharmaceutical Preparations